Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$761K Hold
5,926
1.05% 28
2026
Q1
$713K Hold
5,926
1.14% 25
2025
Q4
$624K Hold
5,926
0.87% 37
2025
Q3
$497K Hold
5,926
0.73% 44
2025
Q2
$469K Hold
5,926
0.76% 39
2025
Q1
$532K Hold
5,926
0.78% 41
2024
Q4
$590K Buy
+5,926
New +$611K 0.87% 35

Other funds holding MRK

KDT Advisors's MRK Position: Q2 2026 in Review

KDT Advisors held its Merck (MRK) position steady in Q2 2026 at 5,926 shares worth $761K. The position accounts for 1.05% of the portfolio, ranked #28.

KDT Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • KDT Advisors held 5,926 shares of Merck worth $761K as of Q2 2026.
  • KDT Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 1.05% of KDT Advisors's portfolio in Q2 2026, its #28 holding.
  • KDT Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on KDT Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.